These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Feng M; Liu L; Guo Z; Xiong Y Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305 [TBL] [Abstract][Full Text] [Related]
6. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234 [TBL] [Abstract][Full Text] [Related]
17. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion. Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305 [TBL] [Abstract][Full Text] [Related]
18. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy. Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280 [TBL] [Abstract][Full Text] [Related]
19. Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease. Wadham C; Mangoni AA Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):303-19. PubMed ID: 19331593 [TBL] [Abstract][Full Text] [Related]
20. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. Selley ML J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]